- Home
- CYCN vs INBS Comparison
CYCN vs INBS Comparison
Compare CYCN & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- INBS
- Stock Information
- Founded
- CYCN 2018
- INBS 2016
- Country
- CYCN United States
- INBS United States
- Employees
- CYCN N/A
- INBS N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- CYCN Health Care
- INBS Health Care
- Exchange
- CYCN Nasdaq
- INBS Nasdaq
- Market Cap
- CYCN 11.8M
- INBS 11.7M
- IPO Year
- CYCN N/A
- INBS N/A
- Fundamental
- Price
- CYCN $2.17
- INBS $1.44
- Analyst Decision
- CYCN
- INBS
- Analyst Count
- CYCN 0
- INBS 0
- Target Price
- CYCN N/A
- INBS N/A
- AVG Volume (30 Days)
- CYCN 58.6K
- INBS 263.5K
- Earning Date
- CYCN 08-05-2025
- INBS 09-18-2025
- Dividend Yield
- CYCN N/A
- INBS N/A
- EPS Growth
- CYCN N/A
- INBS N/A
- EPS
- CYCN N/A
- INBS N/A
- Revenue
- CYCN $2,174,000.00
- INBS $2,936,472.00
- Revenue This Year
- CYCN N/A
- INBS $280.88
- Revenue Next Year
- CYCN N/A
- INBS $126.26
- P/E Ratio
- CYCN N/A
- INBS N/A
- Revenue Growth
- CYCN N/A
- INBS 3.87
- 52 Week Low
- CYCN $1.27
- INBS $1.00
- 52 Week High
- CYCN $9.47
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- CYCN 32.29
- INBS 38.69
- Support Level
- CYCN $2.51
- INBS $1.44
- Resistance Level
- CYCN $2.41
- INBS $1.65
- Average True Range (ATR)
- CYCN 0.25
- INBS 0.15
- MACD
- CYCN -0.07
- INBS -0.03
- Stochastic Oscillator
- CYCN 3.48
- INBS 2.35
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).